Cytek Biosciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €223.44M +6.3% -€9.67M -10.9% -4.3% +0.0083 pp N/A N/A
    (estimated) €210.29M +6.0% -€10.85M -35.0% -5.2% +0.033 pp N/A N/A
    (estimated) €198.33M +9.5% -€16.70M -18.7% -8.4% +0.029 pp N/A N/A
    (estimated) €181.07M +7.1% -€20.54M -8.2% -11.3% +0.019 pp N/A N/A
    (estimated) €168.99M -2.3% -€22.39M +330.9% -13.2% -0.10 pp N/A N/A
    €173.00M +3.9% -€5.20M -50.4% -3.0% +0.033 pp €24.95M +186.0% 14.4% +0.092 pp
    €166.58M +17.7% -€10.48M -571.6% -6.3% -0.079 pp €8.72M -527.8% 5.2% +0.067 pp
    €141.57M +28.2% €2.22M -41.7% 1.6% -0.019 pp -€2.04M -126.3% -1.4% -0.085 pp
    €110.43M +37.8% €3.81M -77.2% 3.5% -0.17 pp €7.76M -46.2% 7.0% -0.11 pp
    €80.12M +60.4% €16.75M -215.4% 20.9% +0.50 pp €14.42M -230.8% 18.0% +0.40 pp
    €49.96M -€14.52M -29.1% -€11.02M -22.1%

    Notifications